Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress

Acta Neuropsychiatrica

Volumn 27, Issue 5, 2015, Pages 312-316

  Yang, Chun ^a   Shirayama, Yukihiko ^a,b   Zhang, Ji Chun ^a   Ren, Qian ^a   Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

interleukin 6 (IL 6); learned helplessness; resilience; susceptible

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; TOCILIZUMAB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; ELECTRIC SHOCK; ENZYME LINKED IMMUNOSORBENT ASSAY; LEARNED HELPLESSNESS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; TISSUE LEVEL; WESTERN BLOTTING; ANIMAL; BLOOD; DISEASE PREDISPOSITION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; DEPRESSION; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELPLESSNESS, LEARNED; INTERLEUKIN-6; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL;

EID: 84941259152     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2015.36     Document Type: Article

References (18)

1. FEDER A, NESTLER EJ, CHARNEY DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 2009;10:446-457.
2. RUSSO SJ, MURROUGH JW, HAN MH, CHARNEY DS, NESTLER EJ. Neurobiology of resilience. Nat Neurosci 2012;15:1475-1484.
3. SOUTHWICK SM, VYTHILINGAM M, CHARNEY DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 2005;1:255-291.
4. YANG C, SHIRAYAMA Y, ZHANG JC, REN Q, HASHIMOTO K. Regional differences in brain-derived neurotrophic factor and dendritic spine density confer resilience to inescapable stress. Int J Neuropsychopharmacol 2015;18:pyu121.
5. DANTZER R, O'CONNOR JC, FREUND GG, JOHNSON RW, KELLY KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-57.
6. RAISON CL, LOWRY CA, ROOK GA. Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry 2010;67:1211-1224.
7. YOUNG JJ, BRUNO D, POMARA N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 2014;169:15-20.
8. DOWLATI Y, HERRMANN N, SWARDFAGER W et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-457.
9. BLACK C, MILLER BJ. Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry 2015; doi: 10.1016/j.biopsych.2014.10.014 [Epub ahead of print].
10. MUNEOKA K, SHIRAYAMA Y, HORIO M, IYO M, HASHIMOTO K. Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness. Psychopharmacology 2013;226:63-71.
11. SHIRAYAMA Y, MUNEOKA K, FUKUMOTO M et al. Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats. Hippocampus 2011;21:1105-1113.
12. HODES GE, PFAU ML, LEBOEUF M et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci USA 2014;111:16136-16141.
13. YANG JJ, WANG N, YANG C, SHI JY, YU HY, HASHIMOTO K. Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry 2015;77:e19-e20.
14. VIRTANEN M, SHIPLEY MJ, BATTY DG et al. Interleukin-6 as a predictor of symptom resolution in psychological distress: a cohort study. Psychol Med 2015;20:1-8. [Epub ahead of print].
15. AGUDELO LZ, FEMENIA T, ORHAN F et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 2014;159:33-45.
16. SCHWARCZ R, BRUNO JP, MUCHOWSKI PJ, WU HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 2012;13:465-477.
17. HASHIMOTO K. Inflammatory biomarkers as differential predictors of antidepressant response. Int J Mol Sci 2015;16:7796-7801.
18. SHETTY A, HANSON R, KORSTEN P et al. Tocilizumab in the treatment of rheumatoid arthritis and beyond. Drug Des Dev Ther 2014;8:349-364.